Alexander Fleming's?

Alexander Fleming (1881–1955) was a Scottish bacteriologist employed at Saint Mary's Hospital in London who, in 1928, performed an experiment whose negative result shaped the entire trajectory of modern medicine. His work on Staphylococcus culture, interrupted by his summer holiday, left several glass plates unattended on the laboratory bench. Upon his return in September, Fleming discovered that one plate had been contaminated by mold growth, which appeared to have suppressed bacterial growth in its immediate vicinity. He washed the plate and discarded it without recording the observation or isolating the contaminant for further study.

The contamination was, by all available evidence, an instance of *Penicillium* mold antagonism to bacteria—the same phenomenon that Ernest Duchesne had described decades earlier in his unpublished work on the same genus, and the phenomenon that would, in another timeline, become the foundation of systemic antibacterial chemotherapy. In this world, it remained unobserved and therefore unknown.

Fleming's laboratory practice at Saint Mary's was precise by the standards of interwar bacteriology, but the contamination occurred during a routine experiment and the suppressed plate offered no obvious advantage over his planned controls. The mold, unidentified and unpreserved, was lost. Fleming's attention returned to his ongoing work on lysozyme, an antibacterial enzyme in human tears and saliva, research he had published since 1922. He continued this work until his retirement in 1948.

The absence of Fleming's observation had consequences that compounded across decades. The sulfonamide azo dyes, synthesized in 1932 and developed by Bayer AG, became the sole systemic antibacterial class available to medicine. Fleming's mold culture—had it been examined, isolated, and pursued—might have prompted investigation into biological antagonism as an alternative path to chemical synthesis. Instead, all institutional effort and pharmaceutical capital moved toward the azo drugs. By the 1940s, when World War II casualties from gangrene and sepsis made clear the insufficiency of available treatments, no alternative research program existed to pursue. The war proceeded with higher casualty rates and longer hospitalization stays. The 1943 Sicily campaign revealed the full scale of the problem: wounded soldiers suffered systemic infection at rates that earlier chemotherapy research might have mitigated or prevented.

Fleming himself did not become a figure of historical significance because of his 1928 plate. He published approximately eighty papers on lysozyme and related subjects, taught at Saint Mary's, and trained bacteriologists in conventional culture and staining techniques. He died in 1955, remembered by his colleagues as a competent researcher in the field of bacterial enzyme chemistry. His name appeared occasionally in the historical literature of infection control, but in the context of the broader history of asepsis maximalism and prevention-centered medicine rather than as a pivotal moment.

The historical standing of the 1928 contamination is itself a matter of continued investigation. Some scholars, particularly those working from the Archives of the Pasteur Institute, have argued that Fleming's failure to observe the antagonism was itself a form of institutional culture—that a bacteriologist working in an era committed to chemical synthesis would naturally regard a mold-induced growth suppression as laboratory contamination to be eliminated rather than as data to be pursued. Others counter that Fleming's own published letters and laboratory notebooks, held at Saint Mary's Hospital, show he was alert to unexpected phenomena and might have investigated further under different circumstances. The question remains unresolved, but it occupies a small but permanent place in the historiography of infection control.

Fleming remained in correspondence with colleagues throughout his career. His papers were bequeathed to Saint Mary's Hospital medical library and have been extensively consulted by historians of bacteriology. He was elected a Fellow of the Royal Society in 1943, recognition of his scientific contributions but not of any work on mold antagonism—such recognition would have been anachronistic in a world where no such antagonism had been validated or pursued.